Evidence map›Paper›PMID 39471823›Full record

ArticleMolecular pharmaceutics2024

[

Cristina Simó, Shayla Shmuel, Alex Vanover, Patrícia M R Pereira

Abstract read
In one paragraph

Article in Molecular pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. MIB guides: [Molecular imaging and biology · 2025
    Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cristina SimóDepartment of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States.ORCID 0000-0002-5980-9379
Shayla ShmuelDepartment of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
Alex VanoverDepartment of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States.
Patrícia M R PereiraDepartment of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri 63110, United States.ORCID 0000-0002-4772-9339

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Reversing Drug Resistance in Tumors with Clickable Antibody PairsR37CA276498 · NCI · WASHINGTON UNIVERSITY · PI Patricia Manuela Ribeiro Pereira · 2023 to 2026
$2.5M
ACQUISITION OF A PRE-CLINICAL SIMULTANEOUS PET/MR SCANNERS10OD018515 · OD · WASHINGTON UNIVERSITY · PI LAFOREST, RICHARD ANDRE · 2016 to 2016
$1.9M
Acquisition of high-resolution PET/CT preclinical imaging instrument at MIRS10OD030403 · OD · WASHINGTON UNIVERSITY · PI SHOGHI, KOORESH ISAAC · 2021 to 2021
$929k
NCI NIH HHS P30 CA091842NCI NIH HHS R37 CA276498NIH HHS S10 OD018515NIH HHS S10 OD030403
6 · The paper itself

Abstract

Positron emission tomography (PET) has potential as a complementary technique to biomarker analysis, especially for human epidermal growth factor receptor 2 (HER2)-expressing tumors characterized by high heterogeneity. In this study, zirconium-89 (

Indexed as

Copper RadioisotopesErb-b2 Receptor Tyrosine KinasesImmunoconjugatesPositron-Emission TomographyTrastuzumabXenograft Model Antitumor AssaysZirconiumAnimalsAntineoplastic Agents, ImmunologicalCell Line, TumorDeferoxamineFemaleHeterocyclic Compounds, 1-RingHumansLovastatinMice1,4,7-triazacyclononane-N,N',N''-triacetic acidAntineoplastic Agents, ImmunologicalCopper-64Copper RadioisotopesDeferoxamineERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesHeterocyclic Compounds, 1-RingImmunoconjugatesLovastatinRadioisotopesRadiopharmaceuticalsTrastuzumabZirconiumZirconium-8964Cu-labeled trastuzumab89Zr-labeled trastuzumabHER2Immuno-PETstatin

Identifiers

PMID39471823
PMCPMC11611601

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.